Radiosynthesis and biological evaluation of 18F-labeled 4-anilinoquinazoline derivative (18F-FEA-Erlotinib) as a potential EGFR PET agent

Radiosynthesis and biological evaluation of 18F-labeled 4-anilinoquinazoline derivative... Bioorganic & Medicinal Chemistry Letters 28 (2018) 1143–1148 Contents lists available at ScienceDirect Bioorganic & Medicinal Chemistry Letters journal homepage: www.elsevier.com/locate/bmcl Radiosynthesis and biological evaluation of F-labeled 4-anilinoquinazoline derivative ( F-FEA-Erlotinib) as a potential EGFR PET agent a,b b a b b b b Shun Huang , Yanjiang Han , Min Chen , Kongzhen Hu , Yongshuai Qi , Penghui Sun , Men Wang , b b b a a,c a,⇑ a,⇑ Hubing Wu , Guiping Li , Quanshi Wang , Zhiyun Du , Kun Zhang , Suqing Zhao , Xi Zheng Department of Pharmaceutical Engineering, Faculty of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou, Guangdong 510006, China Nanfang PET Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China Department of Chemical and Environmental Engineering, Wuyi University, Jiangmen, Guangdong 529020, China article i nfo abstract Article history: Epidermal growth factor receptor (EGFR) has gained significant attention as a therapeutic target. Several Received 15 May 2017 EGFR targeting drugs (Gefitinib and Erlotinib) have been approved by US Food and Drug Administration Revised 18 August 2017 (FDA) and have received high approval in clinical treatment. Nevertheless, the curative effect of these Accepted 25 August 2017 medicines varied http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Bioorganic & Medicinal Chemistry Letters Elsevier

Radiosynthesis and biological evaluation of 18F-labeled 4-anilinoquinazoline derivative (18F-FEA-Erlotinib) as a potential EGFR PET agent

Loading next page...
 
/lp/elsevier/radiosynthesis-and-biological-evaluation-of-18f-labeled-4-J4NqHp93AP
Publisher
Elsevier
Copyright
Copyright © 2017 Elsevier Ltd
ISSN
0960-894x
D.O.I.
10.1016/j.bmcl.2017.08.066
Publisher site
See Article on Publisher Site

Abstract

Bioorganic & Medicinal Chemistry Letters 28 (2018) 1143–1148 Contents lists available at ScienceDirect Bioorganic & Medicinal Chemistry Letters journal homepage: www.elsevier.com/locate/bmcl Radiosynthesis and biological evaluation of F-labeled 4-anilinoquinazoline derivative ( F-FEA-Erlotinib) as a potential EGFR PET agent a,b b a b b b b Shun Huang , Yanjiang Han , Min Chen , Kongzhen Hu , Yongshuai Qi , Penghui Sun , Men Wang , b b b a a,c a,⇑ a,⇑ Hubing Wu , Guiping Li , Quanshi Wang , Zhiyun Du , Kun Zhang , Suqing Zhao , Xi Zheng Department of Pharmaceutical Engineering, Faculty of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou, Guangdong 510006, China Nanfang PET Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China Department of Chemical and Environmental Engineering, Wuyi University, Jiangmen, Guangdong 529020, China article i nfo abstract Article history: Epidermal growth factor receptor (EGFR) has gained significant attention as a therapeutic target. Several Received 15 May 2017 EGFR targeting drugs (Gefitinib and Erlotinib) have been approved by US Food and Drug Administration Revised 18 August 2017 (FDA) and have received high approval in clinical treatment. Nevertheless, the curative effect of these Accepted 25 August 2017 medicines varied

Journal

Bioorganic & Medicinal Chemistry LettersElsevier

Published: Apr 1, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial